Brief: Uk's MHRA Authorises Redemplo For Adults With Familial Chylomicronaemia Syndrome
Mon 16:45
BRIEF-Uk's MHRA Authorises Redemplo For Adults With Familial Chylomicronaemia Syndrome Oct 19 (Reuters) - UK's MHRA:
UK'S MHRA: AUTHORISES PLOZASIRAN (REDEMPLO) FOR ADULTS WITH FAMILIAL CHYLOMICRONAEMIA SYNDROME
Further company coverage: ARWR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arrowhead Pharmaceuticals
See all newsBrief: Uk's MHRA Authorises Redemplo For Adults With Familial Chylomicronaemia Syndrome
US STOCKS ON THE MOVE-Netflix, Coinbase Global, Accenture
US STOCKS ON THE MOVE-Bending Spoons, Skydance, Albertsons
US STOCKS ON THE MOVE-Albertsons, GlobalFoundries, American Electric Power, Fastenal
Brief: Arrowhead Pharmaceuticals Announces ARO-MAPT Interim Phase 1/2a Clinical Data Demonstrating Deep and Durable Tau Reductions in Healthy Volunteers